ANTI-TRAIL Chemische Eigenschaften,Einsatz,Produktion Methoden

R-S?tze Betriebsanweisung:

R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-S?tze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.

Verwenden

Monoclonal Anti-TRAIL antibody produced in mouse has been used in fluorescence-activated cell sorting (FACS).

Allgemeine Beschreibung

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor (TNF) cytokine family. This ligand is a type II transmembrane protein that contains a short cytoplasmic N-terminal domain and a long C-terminal extracellular receptor-binding domain. TRAIL is highly expressed in immune system cells. The TRAIL gene is located on the human chromosome at 3q26.31.

Biochem/physiol Actions

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to TRAIL 1 & 2 receptors and induces apoptosis. This ligand is involved in the homeostasis of T-cells and natural killer (NK) cells. TRAIL also aids in the T-cell-mediated killing of virus-infected cells and oncogenic transformed cells.

ANTI-TRAIL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-TRAIL Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai guandao biology engineering co., ltd	18818239863 18818239863;	3171921642@qq.com	China	9260	58
Atlas antibodies	46-854595850	order@atlasantibodies.com	China	6586	58
Merck KGaA	21-20338288	ordercn@merckgroup.com	China	6038	58
Xirui Trading (Shanghai) Co., Ltd.	dh021-37198115		CHINA	975	58

---

• ANTI-HUMAN TRAIL/APO2L POLYCLONAL ANTIBODY
• ANTI-HUMAN TRAIL, CLONE B-S23, MONOCLONAL ANTIBODY
• ANTI-HUMAN TRAIL, CLONE B-T24, MONOCLONAL ANTIBODY
• MONOCLONAL ANTIBODY TO TRAIL (HUMAN) (2E5)
• MONOCLONAL ANTIBODY TO TRAIL (HUMAN) (5D5)
• MONOCLONAL ANTIBODY TO TRAIL (HUMAN) (HS501)
• MONOCLONAL ANTIBODY TO TRAIL (HUMAN) (LLL6F)
• MONOCLONAL ANTIBODY TO TRAIL (HUMAN) (VI10E)
• Monoclonal Anti-TRAIL antibody produced in mouse
• Monoclonal Anti-CD253, azide free antibody produced in mouse
• ANTI-APO2 LIGAND, HUMAN
• ANTI-APO-2 (HUMAN)
• ANTI-HUMAN APO2L
• ANTI-HUMAN SOLUBLE TNF-RELATED APOPTOSIS INDUCING LIGAND
• ANTI-HUMAN STRAIL
• ANTI-HUMAN TNFSF10
• ANTI-HUMAN TRAIL/APO 2 LIGAND
• ANTI-HUMAN TRAIL/APO2L
• ANTI-HUMAN APO2 LIGAND
• ANTI-CD253 (HUMAN)
• ANTI-APO-2L
• ANTI-TRAIL (APO-2L)
• ANTI-TRAIL
• ANTI-TNF-RELATED APOPTOSIS INDUCING LIGAND (HUMAN)
• ANTI-HUMAN TRAIL, CLONE B-S23
• ANTI-HUMAN TRAIL, CLONE B-T24
• ANTI-HUMAN TRAIL
• ANTI-HUMAN TL2
• ANTI-HUMAN TNF-RELATED APOPTOSIS-INDUCING LIGAND
• Anti-Apo-2L, Anti-TNF-Related Apoptosis-Inducing Ligand, Anti-TNFSF10
• ANTI-TNFSF 10 (HUMAN)
• ANTI-TRAIL(C-19)
• ANTI-TRAIL(H-257)
• ANTI-TRAIL (HUMAN)
• ANTI-TNF-RELATED APOPTOSIS-INDUCING LIGAND
• Anti-TNFSF10